| Yuki Asakura, | |
|
1391 Speer Blvd, Denver, CO 80204-2508 | |
| (303) 561-5010 | |
| Not Available |
| Full Name | Yuki Asakura |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 19 Years |
| Location | 1391 Speer Blvd, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881054013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | APN:0005924-CNS (Colorado) | Primary |
| 363LA2200X | Nurse Practitioner - Adult Health | APN.0005924-CNS (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parker Adventist Hospital | Parker, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Portercare Adventist Health System | 0941110886 | 547 |
News Archive
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The result of some elements of the health law that were initially viewed as victories are now not so clear-cut.
AIDS Healthcare Foundation, the largest global AIDS organization, is spearheading a series of US and global protests targeting the Government of the People's Republic of China to demand that it step up its commitment on global AIDS and pledge one billion dollars to Global Fund to Fight AIDS, TB, and Malaria.
› Verified 6 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The result of some elements of the health law that were initially viewed as victories are now not so clear-cut.
AIDS Healthcare Foundation, the largest global AIDS organization, is spearheading a series of US and global protests targeting the Government of the People's Republic of China to demand that it step up its commitment on global AIDS and pledge one billion dollars to Global Fund to Fight AIDS, TB, and Malaria.
› Verified 6 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The result of some elements of the health law that were initially viewed as victories are now not so clear-cut.
AIDS Healthcare Foundation, the largest global AIDS organization, is spearheading a series of US and global protests targeting the Government of the People's Republic of China to demand that it step up its commitment on global AIDS and pledge one billion dollars to Global Fund to Fight AIDS, TB, and Malaria.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yuki Asakura, 1391 Speer Blvd, Ste 600, Denver, CO 80204-2554 Ph: () - | Yuki Asakura, 1391 Speer Blvd, Denver, CO 80204-2508 Ph: (303) 561-5010 |
News Archive
Families with food-allergic children face a life of constant vigilance and the looming fear of life-threatening allergic reactions. This fear can have a huge impact on an entire family's life, from heightened anxiety to severe limits on their daily activities. Some families cope well with this situation, while others find it extremely stressful and difficult to manage.
In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The result of some elements of the health law that were initially viewed as victories are now not so clear-cut.
AIDS Healthcare Foundation, the largest global AIDS organization, is spearheading a series of US and global protests targeting the Government of the People's Republic of China to demand that it step up its commitment on global AIDS and pledge one billion dollars to Global Fund to Fight AIDS, TB, and Malaria.
› Verified 6 days ago
Mary Bronwyn Long, CNS, ACHPN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1400 Jackson St, Denver, CO 80206 Phone: 303-388-4461 Fax: 303-270-2206 | |
Ms. Donna Strickland, MS, RN, PMHCNS-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 7772 E 8th Pl, Denver, CO 80230 Phone: 303-808-4880 | |
Mrs. Rosalie Jo Bush, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1056 E 19th Ave, Box 395, Denver, CO 80218 Phone: 303-864-5622 Fax: 303-837-2924 | |
Noriko Saito Rothberg, NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2975 Roslyn St, Denver, CO 80238 Phone: 303-399-7900 Fax: 303-399-7999 | |
Kari Fitzpatrick Ballou, MSN, RN, CNOR Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2170 S Parker Rd, #400, Denver, CO 80231 Phone: 303-755-6304 | |
Ms. Kathryn Ann Terrill, MSN, PMHCNS-BC, RXN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 90 Madison Street, Suite 102, Denver, CO 80206 Phone: 720-331-6899 Fax: 720-306-5499 | |
Mrs. Maureen Doran, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 900 S Garfield St, Denver, CO 80209 Phone: 303-744-3086 Fax: 303-744-3086 |